top of page

FDA PDUFA Calendar

The FDA PDUFA Calendar is a chronological calendar of PDUFA target dates. These are dates by which the FDA aims to deliver their decision regarding an NDA or BLA filing. These decisions can however come before the PDUFA target date.

 

The FDA will typically issue one of the following decisions:

  • CRL - complete response letter - rejection letter noting reasons

  • Marketing approval - approved to market under the given label

 

Sometimes the FDA requires an advisory committee meeting prior to the approval decision. This meeting is a public discussion with committee members of various relevant backgrounds, which usually concludes in a vote regarding the efficacy and safety of the drug in question. The FDA is may use this discussion and vote as a guideline for their decision but by no means are bound to this discussion or vote.

Create a free account to search the FDA Catalyst Calendar or start your 7-day free trial of BPIQ Pro today for unlimited access and to see our Big Mover stocks to watch.

Ticker
Drug
Indication
PDUFA Date
FBIO
CUTX-101 (Copper Histidinate)
Menkes Disease
June 30, 2025
REGN
Linvoseltamab (BCMAXCD3)
Multiple myeloma
July 10, 2025
RHHBY
Columvi® + GemOx
Diffuse large B-cell lymphoma (DLBCL)
Jul 20, 2025
REPL
RP1 +Opdivo (nivolumab)
Melanoma
Jul 22, 2025
ASND
TransCon hGH
Adult growth hormone deficiency
July 27, 2025
PTCT
Sepiapterin (PTC923)
PKU (Phenylketonuria)
July 29, 2025
REGN
Odronextamab
Follicular lymphoma (FL) or R/R diffuse large B-cell lymphoma (DLBCL)
July 30, 2025
INSM
Brensocatib (DPP1 inhibitor)
NCFBE (Non-Cystic Fibrosis Bronchiectasis)
August 12, 2025
TNXP
TNX-102 SL (Tonmya™)
FM (Fibromyalgia)
August 15, 2025
CMRX
Dordaviprone (ONC201)
recurrent H3 K27M-mutant diffuse glioma
August 18, 2025
Page 1 of 1

*Want to see all the upcoming FDA catalyst events? Check out our FDA Catalyst Calendar

092226_Generic Apex “Flash Sale” - button.png
bottom of page